These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6292959)

  • 21. The effects of hallucinogens on blind monkeys.
    Siegel RK; Brewster JM; Johnson CA; Jarvik ME
    Int Pharmacopsychiatry; 1976; 11(3):150-6. PubMed ID: 11193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of phencyclidine, SKF 10,047 and related psychotomimetic agents on N-methyl-D-aspartate receptor mediated synaptic responses in rat hippocampal slices.
    Coan EJ; Collingridge GL
    Br J Pharmacol; 1987 Jul; 91(3):547-56. PubMed ID: 3038243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amantadine decreases d-amphetamine stimulation and increases d-amphetamine anorexia in mice.
    Clark R; Smith DH; Vernier VG; Rubin AA
    Proc Soc Exp Biol Med; 1976 Feb; 151(2):434-6. PubMed ID: 1061960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of d-lysergic acid diethylamide, d-2-bromolysergic acid diethylamide, dl-2,5-dimethoxy-4-methylamphetamine and d-amphetamine on classical conditioning of the rabbit nictitating membrane response.
    Harvey JA; Gormezano I; Cool VA
    J Pharmacol Exp Ther; 1982 May; 221(2):289-94. PubMed ID: 6122729
    [No Abstract]   [Full Text] [Related]  

  • 25. Amphetamine: possible site and mode of action for producing anorexia in the rat.
    Leibowitz SF
    Brain Res; 1975 Jan; 84(1):160-7. PubMed ID: 1053933
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of drugs on visually controlled avoidance behavior in rhesus monkeys: a psychophysical analysis.
    Brown H; Bass WC
    Psychopharmacologia; 1967; 11(2):143-53. PubMed ID: 4968293
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of phencyclidine, LSD and amphetamine on neuronal activity in the posterior parietal association cortex of the monkey.
    Hyvärinen J; Laakso M; Roine R; Leinonen L
    Neuropharmacology; 1979 Mar; 18(3):237-42. PubMed ID: 108607
    [No Abstract]   [Full Text] [Related]  

  • 28. Following several days of continuous administration d-amphetamine acquires hallucinogenlike properties.
    Nielsen EB; Lee TH; Ellison G
    Psychopharmacology (Berl); 1980; 68(2):197-200. PubMed ID: 6776566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of phencyclidine, d-amphetamine and pentobarbital on schedule-controlled behavior in rats.
    Segal SA; Moerschbaecher JM; Thompson DM
    Pharmacol Biochem Behav; 1981 Nov; 15(5):807-12. PubMed ID: 7312916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hallucinogenic compounds and swimming response.
    Uyeno ET
    J Pharmacol Exp Ther; 1968 Jan; 159(1):216-21. PubMed ID: 5643945
    [No Abstract]   [Full Text] [Related]  

  • 31. Discriminative stimulus properties of d-amphetamine in pigeons.
    Järbe TU
    Pharmacol Biochem Behav; 1982 Oct; 17(4):671-5. PubMed ID: 6294675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolerance pattern to amphetamine anorexia after selective lesions in the hypothalamic dopaminergic projection.
    Bhakthavatsalam P; Kamatchi GL; Ghosh MN
    Life Sci; 1985 Aug; 37(7):635-43. PubMed ID: 3927095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actions of hallucinogens on ants (Formica pratensis)--II. Effects of amphetamine, LSD and delta-9-tetrahydrocannabinol.
    Frischknecht HR; Waser PG
    Gen Pharmacol; 1978; 9(5):375-80. PubMed ID: 700357
    [No Abstract]   [Full Text] [Related]  

  • 34. Behavioural changes during withdrawal from desmethylimipramine (DMI). I. Interactions with amphetamine.
    Willner P; Montgomery T
    Psychopharmacology (Berl); 1981; 75(1):54-9. PubMed ID: 6795661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists.
    Rasmussen K; Aghajanian GK
    Brain Res; 1986 Oct; 385(2):395-400. PubMed ID: 3096493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action of psychotogenic drugs on single midbrain raphe neurons.
    Aghajanian GK; Foote WE; Sheard MH
    J Pharmacol Exp Ther; 1970 Feb; 171(2):178-87. PubMed ID: 5459056
    [No Abstract]   [Full Text] [Related]  

  • 37. EEG and behavioral aspects of the interaction of anticholinergic hallucinogens with centrally active compounds.
    Itil T; Fink M
    Prog Brain Res; 1968; 28():149-68. PubMed ID: 5699588
    [No Abstract]   [Full Text] [Related]  

  • 38. Catecholaminergic mechanisms of the lateral hypothalamus: their role in the mediation of amphetamine anorexia.
    Leibowitz SF
    Brain Res; 1975 Nov; 98(3):529-45. PubMed ID: 1182535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological evaluation of N-allynormetazocine (SKF 10,047) on the basis of its discriminative stimulus properties in the rat.
    Shannon HE
    J Pharmacol Exp Ther; 1983 Apr; 225(1):144-52. PubMed ID: 6834266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hallucinogens and the inhalants.
    Cohen S
    Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.